FAQ: GlobalDRO.org / United States Anti-Doping Agency (USADA)

Education is one of the core components of USADA’s anti-doping program and we work to provide athletes with the resources they need to compete clean.

There are times in an athlete’s career where they might have a legitimate medical need to take a medication and USADA has several resources available to assist athletes in determining if their medication is prohibited or not. The primary resources are the Wallet Card, Drug Reference Line, and GlobalDRO.com.

GlobalDRO is a medication database that provides information about the prohibited status of specific drugs/substances based on the current World Anti-Doping Agency (WADA) Prohibited List.

The easy-to-use website is a partnership between USADA, the Canadian Centre for Ethics in Sports (CCES), and UK Anti-Doping (UKAD). The Japan Anti-Doping Agency (JADA) is also an official Global DRO licensee. Thus, visitors can search for specific information on products sold in the United States, Canada, the United Kingdom, and Japan.

It is important to know that GlobalDRO does not contain information on, or that applies to, any dietary supplement which also includes homeopathic products, traditional medicines, herbals, and probiotics.

Do not use GlobalDRO to search for the individual ingredients in a dietary supplement. The dietary supplement may contain prohibited substances even if your search results say the ingredients on the label are not prohibited. The use of any dietary supplement is at your own risk.

To find the status of a medication in sport, follow these easy steps:

1. Go to GlobalDRO.com, choose your sport nationality, select ‘Go’, then ‘Drug Search’ on the following page.

2. Read the Terms and Conditions, check the box saying you understand, and select ‘Search for Medications’.

3. Select your user type, sport, nation of purchase, then enter the brand name (e.g., Tylenol), ingredient (acetaminophen), or Drug Identification Number (DIN) of the medication you wish to find the status of.

4. Find the result that matches the medication you wish to take and select ‘View Status’

http://www.usada.org/how-to-use-global-dro/

FAQ: Testing / United States Anti-Doping Agency (USADA)

Testing is an important part of any effective anti-doping program, and the area that most often comes to mind when thinking about anti-doping. From test planning and collection of a urine or blood sample, through the results managements process, USADA provides a thorough program, with policies and procedures in accordance with the World Anti-Doping Code, the WADA International Standards, the United States Olympic Committee Anti-Doping Rules, and the USADA Protocol for Olympic and Paralympic Movement Testing.

http://www.usada.org/testing/

FAQ: Play Clean Tip Center / United States Anti-Doping Agency (USADA)

In its mission to preserve the integrity of competition, inspire true sport, and protect the rights of athletes, USADA is unwavering in its belief that every athlete has the right to compete on a clean and level playing field, free from the pressures and influences of performance-enhancing drugs. For this reason, USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition.

You may report a tip using one of the following methods:

- Anonymous Tip
- Email
- Phone
- Mail

http://www.usada.org/athletes/playclean/

New Athlete Express Website and App / United States Anti-Doping Agency (USADA)

Learn about the faster, easier, and more intuitive Athlete Express whereabouts website and app.

USADA has recently launched a brand new tool to help support clean athletes as they file and update whereabouts. The Athlete Express whereabouts website and mobile app are designed to make filing whereabouts faster and easier, while assisting athletes to provide better information to USADA.

http://www.usada.org/usada-launches-new-whereabouts-tools-to-support-clean-athletes/

https://athlete.usada.org/Account/Login?ReturnUrl=%2F

FAQ: 60-Minute Window / United States Anti-Doping Agency (USADA)

USADA staff answers the question: "Why are you testing me when it isn't my one-hour window?"

Whereabouts are an extremely critical component of an anti-doping program to facilitate out-of-competition testing and to deter and detect doping. In 2011, a population of USADA Registered Testing Pool (RTP) athletes who are included in the USADA International Testing Pool (ITP) will be required to provide a 60-minute time slot as part of their whereabouts requirements. The 60-minute time slot, in addition to other whereabouts requirements, is the athlete’s responsibility and the bullet points provide answers to the most frequently asked questions.

https://athlete.usada.org/Account/Login?ReturnUrl=%2F

http://www.usada.org/testing/whereabouts/

The Simple Truth : Decoding the Dietary Supplement Industry / United States Anti-Doping Agency (USADA)

The United States Anti-Doping Agency (USADA) produced this three-minute video that explains the intricacies of the vitamin and supplement industry and how athletes can avoid making uninformed choices.

In February 2016 the Nederlandse Rugby Bond (NRB), the Dutch Rugby Union, has reported an anti-doping rule violation against the Athlete after his sample tested positive for the prohibited substance cannabis with a high concentration above the WADA threshold.

Because the foreign Athlete already had left the country several attempts were made to contact him in his own country. Because the Athlete failed to respond the ISR-NRB Disciplinary Committee decides on 12 April 2016 to impose a 2 year period of ineligibility on the Athlete. Fees and expenses for this committee shall be borne by the Athlete.

In January 2016 the Spanish Agency for the Protection of Health in Sport (Agencia Española de Protección de la Salud en el Deporte, AEPSAD) has reported an anti-doping rule violation against the respondent E50 after his sample tested positive for the prohibited substances cocaine and cannabis.

After notification the respondent filed a statement with objections in his defence. The respondent disputed several irregularities in the sample collection, the chain of custody, the laboratory and the analysis of the sample. Also the respondent requested to receive all the relevant documentation about the performed procedures in this case.

AEPSAD finds that the respondent failed in his responsibility that no prohibited substances enter his body; dismiss the respondent’s objections; and concludes that the sample collection, transport en analysis were performed in accordance with the Rules.
Considering aggravating circumstances due to the respondent tested positive for cocaine and cannabis AEPSAD decides on 18 March 2016 to impose a 4 year period of ineligibililty on the respondent starting on the date of the decision.

In December 2015 the Spanish Agency for the Protection of Health in Sport (Agencia Española de Protección de la Salud en el Deporte, AEPSAD) has reported an anti-doping rule violation against the respondent E49 after his sample tested positive for the prohibited substance cocaine.

After notification a provisional suspension was ordered and the respondent filed a statement in his defence. The respondent admitted the violation and gave an explanation about the circumstances resulting in the positive test result. He requested to limit the annulment of competition results and not to publish the anti-doping decision because of damage to his reputation.

Considering the circumstances AEPSAD decides on 23 March 2016 as settlement to impose a 2 year period of ineligibility on the respondent starting on the date of the provisional suspension including forfeiture of the results won in the competitions and a € 3001,- fine.

In December 2015 the Spanish Agency for the Protection of Health in Sport (Agencia Española de Protección de la Salud en el Deporte, AEPSAD) has reported an anti-doping rule violation against the respondent E48 after his sample tested positive for the prohibited substance chlorothiazide.

After notification the respondent filed a statement, sustained by medical evidence, in his defence. The respondent admitted the violation and submitted that he used the substance as prescribed medication to treat his hypertension.

Considering the circumstances AEPSAD decides on 9 March 2016 to impose a 1 year period of ineligibility on the respondent starting on the date of the sample collection.